Małopolskie Centrum Sercowo-Naczyniowe AhoP

The medical center is at the forefront of vascular medicine, focusing on innovative treatments for lower extremity artery disease. The center's research explores the use of oral colchicine to prevent restenosis in the superficial femoral artery, offering new hope for patients with this condition.

• Restenosis prevention
• Oral colchicine therapy
• Uncoated vascular stents

By comparing the efficacy of oral colchicine with drug-eluting stents, the center aims to enhance treatment protocols and improve patient outcomes in vascular interventions.

In the realm of cardiology, the center is pioneering research on the "cooling" effect of metformin in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome. This study is particularly focused on nondiabetic patients, aiming to reduce the rate of unplanned coronary revascularization.

• Metformin's cardiovascular effects
• Acute coronary syndrome management
• PCI treatment advancements

Through this research, the center is contributing to a deeper understanding of metformin's potential benefits beyond diabetes management, potentially transforming therapeutic strategies in cardiology.